On August 27, IBM rose 3.07% in regular trading, trading at $236.53/share, with turnover of $191 million. The stock gained momentum following the company's announcement that it has completed the acquisition of HRL Laboratories.

HRL Laboratories is a leading research and development institution specializing in quantum computing, quantum sensing, advanced communications, electronics, manufacturing, and materials science. The acquisition brings silicon-based quantum technology expertise that complements IBM's existing superconducting quantum computing hardware. HRL's capabilities also create collaboration opportunities with IBM's pure quantum wafer foundry Anderon, supporting scalable manufacturing methods to accelerate multiple quantum computing modalities. Boeing and General Motors, as former owners of HRL, will continue to collaborate with IBM and HRL on quantum applications and advanced technology development. Financial terms of the deal were not disclosed.

Additionally, IBM recently unveiled the world's first dual-architecture mainframe processor featuring 2nm technology, 11 cores running above 5.7GHz, capable of processing both Arm and IBM instructions simultaneously on a single core, further expanding its enterprise computing ecosystem.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)